{"disease":{"id":"sorafenib","name":"sorafenib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07463651","title":"MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":594,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04103398","title":"TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03535259","title":"Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04709380","title":"Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04518852","title":"TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT06592989","title":"A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03958669","title":"Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}